Dashboard
Manage Tickers

FEMYFEMASYS INC

Nasdaq femasys.com


$ 1.26 $ -0.01 (-0.79 %)    

Friday, 10-May-2024 09:51:30 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.56 $ -1.36 (-0.31 %)
DIA $ 394.60 $ -0.68 (-0.17 %)
SPY $ 520.45 $ -1.02 (-0.2 %)
TLT $ 90.08 $ -0.23 (-0.25 %)
GLD $ 218.78 $ -1.00 (-0.46 %)
$ 1.27
$ 1.26
$ 1.25 x 400
$ 0.00 x 0
$ 1.26 - $ 1.26
$ 0.25 - $ 4.75
235,599
na
27.65M
$ 0.17
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-28-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-30-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-10-2022 06-30-2022 10-Q
9 05-11-2022 03-31-2022 10-Q
10 03-24-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-11-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-femasys-maintains-13-price-target
HC Wainwright & Co. Reiterates Buy on Fema...
05/09/2024 17:40:40

HC Wainwright & Co. analyst Emily Bodnar reiterates Femasys (NASDAQ:FEMY) with a Buy and maintains $13 price target.

femasys-q1-2024-gaap-eps-017-beats-019-estimate-sales-271140k-miss-776500k-estimate
Femasys Q1 2024 GAAP EPS $(0.17) Beats $(0...
05/09/2024 12:41:08

Femasys (NASDAQ:FEMY) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.19) by 10...

chardan-capital-maintains-buy-on-femasys-maintains-12-price-target
Chardan Capital Maintains Buy on Femasys, ...
04/01/2024 12:25:20

Chardan Capital analyst Keay Nakae maintains Femasys (NASDAQ:FEMY) with a Buy and maintains $12 price target.

hc-wainwright--co-maintains-buy-on-femasys-raises-price-target-to-12
HC Wainwright & Co. Maintains Buy on Femas...
04/01/2024 10:43:45

HC Wainwright & Co. analyst Emily Bodnar maintains Femasys (NASDAQ:FEMY) with a Buy and raises the price target from $10...

femasys-q4-eps-019-beats-021-estimate-sales-21311k-miss-24000k-estimate
Femasys Q4 EPS $(0.19) Beats $(0.21) Estim...
03/29/2024 03:38:55

Femasys (NASDAQ:FEMY) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.21) by 9....

chardan-capital-reiterates-buy-on-femasys-maintains-12-price-target
Chardan Capital Reiterates Buy on Femasys,...
03/21/2024 16:54:09

Chardan Capital analyst Keay Nakae reiterates Femasys (NASDAQ:FEMY) with a Buy and maintains $12 price target.

hc-wainwright--co-reiterates-buy-on-femasys-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Fema...
03/21/2024 10:29:26

HC Wainwright & Co. analyst Emily Bodnar reiterates Femasys (NASDAQ:FEMY) with a Buy and maintains $10 price target.

femasys-announces-topline-data-from-pivotal-trial-for-femaseed-for-treatment-of-infertility-says-in-the-severe-male-factor-cohort-findings-show-24-of-women-became-pregnant-after-femaseed-femaseed-pregnancy-rate-by-cycle-was-more-than-double-historic-intrauterine-insemination-rate
Femasys Announces Topline Data From Pivota...
03/20/2024 12:18:26

femasys-completes-first-in-office-commercial-procedure-with-femaseed-infertility-solution
Femasys Completes First In-Office Commerci...
03/06/2024 14:02:20

femasys-highlights-its-femaseed-product-says-it-is-expected-to-serve-as-a-first-line-therapeutic-option-that-is-substantially-lower-cost-with-significantly-less-risk-than-assisted-reproductive-methods
Femasys Highlights Its FemaSeed Product, S...
02/28/2024 14:03:53

first-lady-jill-biden-unveils-100m-in-federal-funding-to-support-rd---watch-out-for-these-women-health-stocks
First Lady Jill Biden Unveils $100M In Fed...
02/21/2024 17:24:52

Jill Biden announces $100 million in federal funding for women's health research, addressing underfunding and lack of aware...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
02/19/2024 21:30:44

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
02/08/2024 17:31:40

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
02/07/2024 17:31:16

femasys-begins-fembloc-pivotal-trial-enrollment-to-investigate-the-safety-and-efficacy-of-its-investigational-permanent-birth-control-candidate-fembloc
Femasys Begins FemBloc Pivotal Trial Enrol...
01/26/2024 13:05:39

femasys-inc-begins-fembloc-pivotal-trial-enrollment-at-stanford-medicine-fembloc-is-being-developed-as-a-first- of-its-kind-non-surgical-permanent-birth-control-with-a-clearly-defined-us-regulatory-pathway
Femasys Inc. Begins FemBloc Pivotal Trial ...
12/15/2023 13:34:19

- Stanford Medicine, a center with a long tradition of leadership in pioneering gynecological research and innovation, is the s...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
12/14/2023 13:07:41

femasys-inc-completes-enrollment-of-femaseed-pivotal-trial-in-support-of-commercial-launch
Femasys Inc. Completes Enrollment Of FemaS...
11/28/2023 13:33:42

- Topline results from FemaSeed® pivotal trial expected in 1H 2024 - - Commercial launch planned for early 2024 -ATLANTA, Nov. ...

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
11/24/2023 13:06:43

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
11/23/2023 21:30:57

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION